Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OFFICE OF REGULATORY AFFAIRS DECENTRALIZATION PLAN TO REDUCE HQ STAFF

Executive Summary

OFFICE OF REGULATORY AFFAIRS DECENTRALIZATION PLAN TO REDUCE HQ STAFF by 10%-15% per year over five years will require "moving more and more activities out to the field organizations," FDA Deputy Associate Commissioner for Regulatory Affairs Gary Dykstra told the PDA/FDA Joint Conference in Bethesda, Md, Sept, 20, "We have to do the same amount of work with less people" because of budget constraints and staff reductions mandated as part of Vice- President Gore's National Performance Review report, Dykstra explained.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS025088

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel